Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience

por Gangat, Naseema, Oliveira, Jennifer L., Porter, Tavanna R, Hoyer, James D., Al-Kali, Aref, Patnaik, Mrinal M, Pardanani, Animesh, Tefferi, Ayalew
Publicado 2022